Literature DB >> 20816167

Beta3GnT2 (B3GNT2), a major polylactosamine synthase: analysis of B3GNT2-deficient mice.

Akira Togayachi1, Yuko Kozono, Atsushi Kuno, Takashi Ohkura, Takashi Sato, Jun Hirabayashi, Yuzuru Ikehara, Hisashi Narimatsu.   

Abstract

The polylactosamine structure is a fundamental structure of carbohydrate chains and carries a lot of biofunctional carbohydrate epitopes. To investigate the biological function of polylactosamine chains, here we generated and analyzed knockout mice lacking the gene B3gnt2, which encodes a major polylactosamine synthase. In beta1,3-N-acetylglucosaminyltransferase (B3gnt2) B3gnt2-deficient (B3gnt2-/-) mice, the number of polylactosamine structures was markedly lower than in wild-type mice. Flow cytometry, LEL lectin-blotting, and glycan analysis by metabolic labeling demonstrated that the amount of polylactosamine chains on N-glycans was greatly reduced in the tissues of B3gnt2-/- mice. We examined whether immunological abnormalities were present in B3gnt2-/- mice. We screened polylactosamine-carrying molecules of wild-type mice by lectin microarray analysis and found that polylactosamine was present on CD28 and CD19, two established immune co-stimulatory molecules. Polylactosamine levels on these molecules were lower in B3gnt2-/- mice than in wild-type mice. B3gnt2-/- T cells were more sensitive to the induction of intracellular Ca2+ flux on stimulation with anti-CD3epsilon/CD28 antibodies and proliferated more strongly than wild-type T cells. B3gnt2-/- B cells also showed hyperproliferation on BCR stimulation. These results showed that hyperactivation of lymphocytes occurred due to a lack of polylactosamine on receptor molecules in B3gnt2-/- mice. This finding indicates that polylactosamine has an important role in immunological biofunctions. We can therefore attempt to identify the in vivo biological function of glycans using glycogene-deficient mice. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20816167     DOI: 10.1016/S0076-6879(10)79011-X

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  21 in total

1.  Identification of β1,3-galactosyltransferases responsible for biosynthesis of insect complex-type N-glycans containing a T-antigen unit in the honeybee.

Authors:  Tomomi Ichimiya; Megumi Maeda; Shou Sakamura; Masato Kanazawa; Shoko Nishihara; Yoshinobu Kimura
Journal:  Glycoconj J       Date:  2015-05-01       Impact factor: 2.916

2.  Glycosyltransferase genes that cause monogenic congenital disorders of glycosylation are distinct from glycosyltransferase genes associated with complex diseases.

Authors:  Hiren J Joshi; Lars Hansen; Yoshiki Narimatsu; Hudson H Freeze; Bernard Henrissat; Eric Bennett; Hans H Wandall; Henrik Clausen; Katrine T Schjoldager
Journal:  Glycobiology       Date:  2018-05-01       Impact factor: 4.313

3.  The N-acetyl-binding pocket of N-acetylglucosaminyltransferases also accommodates a sugar analog with a chemical handle at C2.

Authors:  Marta Pasek; Boopathy Ramakrishnan; Elizabeth Boeggeman; Natalia Mercer; Andres E Dulcey; Gary L Griffiths; Pradman K Qasba
Journal:  Glycobiology       Date:  2011-08-25       Impact factor: 4.313

4.  Helicobacter pylori β1,3-N-acetylglucosaminyltransferase for versatile synthesis of type 1 and type 2 poly-LacNAcs on N-linked, O-linked and I-antigen glycans.

Authors:  Wenjie Peng; Jennifer Pranskevich; Corwin Nycholat; Michel Gilbert; Warren Wakarchuk; James C Paulson; Nahid Razi
Journal:  Glycobiology       Date:  2012-07-11       Impact factor: 4.313

5.  Altered glycosyltransferases in colorectal cancer.

Authors:  Srividya Venkitachalam; Kishore Guda
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2016-11-04       Impact factor: 3.869

Review 6.  Advances in the genetics of spondyloarthritis and clinical implications.

Authors:  Darren D O'Rielly; Proton Rahman
Journal:  Curr Rheumatol Rep       Date:  2013-08       Impact factor: 4.592

7.  Attenuation of fibroblast growth factor signaling by poly-N-acetyllactosamine type glycans.

Authors:  Kazuhiro Sugihara; Toshiaki K Shibata; Kayoko Takata; Takako Kimura; Naohiro Kanayama; Roy Williams; Shingo Hatakeyama; Tomoya O Akama; Chu-Wei Kuo; Kay-Hooi Khoo; Michiko N Fukuda
Journal:  FEBS Lett       Date:  2013-08-19       Impact factor: 4.124

Review 8.  What Have We Learned from Glycosyltransferase Knockouts in Mice?

Authors:  Pamela Stanley
Journal:  J Mol Biol       Date:  2016-03-31       Impact factor: 5.469

9.  Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity.

Authors:  Lam C Tsoi; Sarah L Spain; Jo Knight; Eva Ellinghaus; Philip E Stuart; Francesca Capon; Jun Ding; Yanming Li; Trilokraj Tejasvi; Johann E Gudjonsson; Hyun M Kang; Michael H Allen; Ross McManus; Giuseppe Novelli; Lena Samuelsson; Joost Schalkwijk; Mona Ståhle; A David Burden; Catherine H Smith; Michael J Cork; Xavier Estivill; Anne M Bowcock; Gerald G Krueger; Wolfgang Weger; Jane Worthington; Rachid Tazi-Ahnini; Frank O Nestle; Adrian Hayday; Per Hoffmann; Juliane Winkelmann; Cisca Wijmenga; Cordelia Langford; Sarah Edkins; Robert Andrews; Hannah Blackburn; Amy Strange; Gavin Band; Richard D Pearson; Damjan Vukcevic; Chris C A Spencer; Panos Deloukas; Ulrich Mrowietz; Stefan Schreiber; Stephan Weidinger; Sulev Koks; Külli Kingo; Tonu Esko; Andres Metspalu; Henry W Lim; John J Voorhees; Michael Weichenthal; H Erich Wichmann; Vinod Chandran; Cheryl F Rosen; Proton Rahman; Dafna D Gladman; Christopher E M Griffiths; Andre Reis; Juha Kere; Rajan P Nair; Andre Franke; Jonathan N W N Barker; Goncalo R Abecasis; James T Elder; Richard C Trembath
Journal:  Nat Genet       Date:  2012-11-11       Impact factor: 38.330

10.  Differential expression patterns of N-acetylglucosaminyl transferases and polylactosamines in uterine lesions.

Authors:  A T R Clark; V M L Guimarães da Costa; L Bandeira Costa; C L Bezerra Cavalcanti; M J B De Melo Rêgo; E I C Beltrão
Journal:  Eur J Histochem       Date:  2014-05-26       Impact factor: 3.188

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.